June 2024
1. ETXEBERRIA A, Shen YA, Vito S, Silverman S, et al
   Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis.
   J Neurosci. 2024 Jun 3:e2347232024. doi: 10.1523/JNEUROSCI.2347-23.2024.
   

   >> Share

   
   May 2023
2. XUE S, Lozinski BM, Ghorbani S, Ta K, et al
   Elevated galectin-3 is associated with aging, multiple sclerosis, and oxidized phosphatidylcholine induced neurodegeneration.
   J Neurosci. 2023 May 17:JN-RM-2312-22. doi: 10.1523/JNEUROSCI.2312-22.2023.
   

   >> Share

   
   October 2022
3. SORRENTINO P, Petkoski S, Sparaco M, Troisi Lopez E, et al
   Whole-brain propagation delays in multiple sclerosis, a combined tractography - magnetoencephalography study.
   J Neurosci. 2022 Oct 10. pii: JNEUROSCI.0938-22.2022.
   

   >> Share

   
   August 2022
4. FEINBERG PA, Becker SC, Chung L, Ferrari L, et al
   Elevated TNF-alpha Leads to Neural Circuit Instability in the Absence of Interferon Regulatory Factor 8.
   J Neurosci. 2022;42:6171-6185.
   

   >> Share

   
   
5. ROCZKOWSKY A, Doan MAL, Hlavay B, Mamik MK, et al
   Peroxisome injury in multiple sclerosis: protective effects of 4-phenylbutyrate in CNS-associated macrophages.
   J Neurosci. 2022 Aug 8. pii: JNEUROSCI.0312-22.2022.
   

   >> Share

   
   August 2020
6. LEI Z, Yue Y, Stone S, Wu S, et al
   NF-kappaB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE.
   J Neurosci. 2020;40:6444-6456.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share